Singular Genomics Systems
Latest round
- Seed
Last raised
- Jan 2016
Total raised
- Undisclosed
Investors
- 1
About Singular Genomics Systems
Based in California, US, and founded in 2016 by Drew Spaventa and Eli Glezer, Singular Genomics is a biotechnology company focused on providing advanced genomic sequencing technologies to enhance DNA analysis speed and accuracy, addressing critical challenges in genomics. The company is trading on the Nasdaq Global Select Market under the ticker symbol OMIC. In December 2024, Deerfield Management acquired Singular Genomics Systems, Inc. for USD 20 per share, in a public-to-private deal. Singular Genomics offers a G4 instrument that is a next-generation sequencer (NGS) to produce genetic sequencing results and an associated menu of consumable kits. In addition, the company provides PX integrated solution that combines single-cell analysis, proteomics, genomics, and spatial analysis under one integrated instrument offering multi-omics solutions. These systems are primarily utilized in research institutions, laboratories, and clinical settings, serving customers who require precision and efficiency in genomic research. The company’s solutions aim to facilitate advancements in personalized medicine, disease research, and evolutionary studies, with products designed for a global market that includes North America, Europe, and Asia. The December 2024 acquisition will enable Singular Genomics to enhance its technologies and business development. Moreover, the company plans to develop new products aimed at expanding its offerings in genomic sequencing. Additionally, Singular Genomics is targeting expansions into new markets within Europe and Asia by 2025.
Who invested in Singular Genomics Systems
1 investor across 1 round
See all investors in Singular Genomics Systems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 1, 2016
Amount
Undisclosed
Investors
Questions about Singular Genomics Systems
Who invested in Singular Genomics Systems?
Singular Genomics Systems has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Singular Genomics Systems raised?
Singular Genomics Systems has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Singular Genomics Systems last raise money?
Singular Genomics Systems's most recent round on record is a Seed, in Jan 2016.
What does Singular Genomics Systems do?
Based in California, US, and founded in 2016 by Drew Spaventa and Eli Glezer, Singular Genomics is a biotechnology company focused on providing advanced genomic sequencing technologies to enhance DNA analysis speed and accuracy, addressing critical challenges in genomics.
Where is Singular Genomics Systems headquartered?
Singular Genomics Systems is headquartered in San Diego, US.
Which VCs invest in companies like Singular Genomics Systems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Singular Genomics Systems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Singular Genomics Systems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.